Baricitinib for the treatment of rheumatoid arthritis

Rheumatoid arthritis (RA) is a common inflammatory disease with several implications on health, disability and economy. Conventional treatment for RA centers on anti-inflammatory drugs and specific targeting of tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6). Baricitinib is a novel, Food an...

Descripción completa

Detalles Bibliográficos
Autores principales: Urits, Ivan, Israel, Jacob, Hakobyan, Hayk, Yusin, George, Lassiter, Grace, Fackler, Nathan, Berger, Amnon A., Kassem, Hisham, Kaye, Alan, Viswanath, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2020
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792534/
https://www.ncbi.nlm.nih.gov/pubmed/33456084
http://dx.doi.org/10.5114/reum.2020.102006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792534/
https://www.ncbi.nlm.nih.gov/pubmed/33456084
http://dx.doi.org/10.5114/reum.2020.102006

Ejemplares similares